GS
NVAX icon

George Soros’s Novavax NVAX Stock Holding History

George Soros’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,515
Closed -$156K – 223
2016
Q1 		$156K Buy
+1,515
New +$163K ﹤0.01% 219
2013
Q4 		– Sell
-28,650
Closed -$1.81M – 272
2013
Q3 		$1.81M Buy
+28,650
New +$1.61M 0.02% 200

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

George Soros's NVAX Position: Q2 2016 in Review

George Soros sold out of Novavax (NVAX) in Q2 2016, closing a stake of 1,515 shares — an estimated $156K sold.

George Soros first reported a position in NVAX in Q3 2013 and held it in 2 quarters. The position peaked at $1.81M in Q3 2013. 187 funds tracked by Wall St. Rank hold NVAX as of Q2 2016.

  • George Soros reported no remaining Novavax position as of Q2 2016 after selling out during the quarter.
  • George Soros sold 1,515 Novavax shares in Q2 2016, an estimated $156K.
  • George Soros first reported a position in Novavax in Q3 2013 and held it in 2 quarters.
  • George Soros's Novavax position peaked at $1.81M in Q3 2013.
  • 187 funds tracked by Wall St. Rank held Novavax as of Q2 2016.

Based on Soros Fund Management's 13F filing for Q2 2016, filed 15 Aug 2016.